Galena Biopharma&#44&#59; Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (50)

Latest Posts

About This Stock More About This Stock
E RXi Pharmaceuticals: Extreme Volatility Attracts Traders, But Long-Term Worries Persist
Article By: Quad 7 Capital
Tuesday, March 27, 2018 2:28 PM EDT
Although RXi Pharmaceuticals burnt far less cash than expected, the company and management have given little in the way of anticipated 2018 plans or data reads which shareholders desperately need if this stock is to survive.
In this article: RXII
Read
RXi Pharmaceuticals Receives Japanese Patent For RNAi Platform
Article By: The Life Sciences Report
Thursday, April 13, 2017 1:17 PM EDT
With the granting of a new patent in Japan for its lead compound, RXI-109, RXI Pharmaceuticals has strengthened its reach in Asian markets and enhanced the protections surrounding its proprietary RNAi platform.
In this article: RXII
Read
E Rxi Pharmaceuticals Obtains Partnership Agreement For ALS With Thera Neuropharma
Article By: Terry Chrisomalis
Tuesday, May 3, 2016 10:43 AM EDT
The license agreement expands on the notion that Thera NeuroPharma will use Rxi's sd-rxRNA technology platform to develop neurodegenerative disease medicines.
In this article: RXII
Read
E Rxi Pharmaceuticals To Present Pre-Clinial Data At 2016 ARVO Conference
Article By: Terry Chrisomalis
Tuesday, April 19, 2016 2:40 AM EDT
Rxi is attempting to provide a topical gel whereby the patient can apply topical gel to the cornea, where the scar is, and be able to reduce scars. This is intended to reduce vision loss/blindness.
In this article: RXII
Read
E RXi Pharmaceuticals Patent And Conference Call News Update
Article By: Terry Chrisomalis
Friday, April 1, 2016 10:13 AM EDT
Rxi Pharmaceuticals Patent And Conference Call News Update
In this article: RXII
Read

PARTNER HEADLINES

Latest Tweets for $RXII

No tweets yet!

$RXII

RXi Pharmaceuticals: Keeping A Large Focus On Shareholder Value Creation In 2016
Cristina Portuondo 12/30/2015 12:02:49 AM

$RXII has proved very disappointing, but I haven't completely given up on this stock yet.

1 to 1 of 1 comments